NewLimit, Inc.
Biotechnology company · South San Francisco, California, United States
NewLimit, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $130 million sold in a notice filed in 2025.
NewLimit at a glance
What does NewLimit do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $129.8 million sold (2025).
Frequently asked questions about NewLimit
Where is NewLimit headquartered?
NewLimit, Inc. is headquartered in South San Francisco, California, United States.
What does NewLimit do?
NewLimit, Inc. is a biotechnology company.
When was NewLimit founded?
The earliest incorporation on record for NewLimit, Inc. is in 2021, according to public company registers.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences